Andreas Busch's Insider Trades & SAST Disclosures

Andreas Busch's most recent trade in Absci Corp was a trade of 100,000 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on March 12, 2026.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Absci Corp
Andreas Busch Chief Innovation Officer Purchase of securities on an exchange or from another person at price $ 2.29 per share. 12 Mar 2026 100,000 421,446 - 2.3 229,000 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.80 per share. 03 Mar 2026 1,257 321,446 - 2.8 3,520 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer 03 Feb 2026 1,469 322,703 - 3.0 4,392 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer 14 Oct 2025 3,092 324,172 - 3.7 11,379 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer 28 Jul 2025 50,000 327,264 - 3.0 152,000 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer 03 Mar 2025 93,700 93,700 - - Stock Option (right to buy)
Absci Corp
Andreas Busch Chief Innovation Officer 03 Mar 2025 23,700 277,264 - 0 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer 01 Feb 2025 1,469 253,564 - 3.7 5,450 Common Stock
Absci Corp
Busch Andreas Chief Innovation Officer 12 Oct 2024 3,092 255,033 - 4.1 12,584 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer 01 Feb 2024 349,625 349,625 - - Stock Option (right to buy)
Absci Corp
Andreas Busch Chief Innovation Officer 01 Feb 2024 83,125 258,125 - 0 Common Stock
Absci Corp
Andreas Busch Chief Innovation Officer 01 Mar 2023 550,000 550,000 - - Stock Option (right to buy)
Absci Corp
Andreas Busch Chief Innovation Officer 03 Oct 2022 2,000,009 2,000,009 - - Stock Option (right to buy)
Absci Corp
Andreas Busch Director 08 Jun 2022 4,783 4,783 - - Stock Option (right to buy)
Absci Corp
Andreas Busch Director 17 Mar 2022 45,180 45,180 - - Stock Option (right to buy)
Cyclerion Therapeutics Inc
Andreas Busch Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2022 135,000 135,000 - - Employee Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades